TrialX provides cutting-edge information on new medical treatments and clinical trials in your area.
Meet Dory , your personalized virtual assistant to find clinical trials. Go head, ask her anything. x
All > Illinois Investigators

Laura E. Horvath

Central DuPage Hospital

Winfield, Illinois - 60190

Central Dupage Cancer Center

Winfield, Illinois - 60190 (708-216-9000)
  • SINCE2007
Efficacy and Safety of MORAb-003 in Subjects With Platinum-sensitive Ovarian Cancer in First Relapse

March 2009 - September 2012
Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer

July 2009 - June 2012
Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

April 2008 - January 2010
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB Recurrent or Persistent Cervical Cancer

April 2009 - December 2011
Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II Stage III or Stage IV Ovarian Epithelial Cancer Fallopian Tube Cancer or Primary Peritoneal Cancer

August 2009 - January 2016
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy Paclitaxel and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer

March 2009 - March 2013
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage III or Stage IVA Endometrial Cancer

June 2009 - December 2013
Doxorubicin Cyclophosphamide and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk Lymph Node-Negative Breast Cancer

November 2007 - November 2013
Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I Stage II or Stage IIIA Breast Cancer Undergoing Chemotherapy

September 2009 - January 2012
An Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian Cancer

September 2008 - October 2014
Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer Primary Peritoneal Cavity Cancer or Fallopian Tube Cancer Undergoing Chemotherapy

September 2007 -
Breast Neoplasms

Lung Neoplasms

Ovarian Neoplasms


Carcinoma, Non-Small-Cell Lung

Peritoneal Neoplasms

Fallopian Tube Neoplasms

Neurotoxicity Syndromes

Endometrial Neoplasms

Uterine Cervical Neoplasms


Peripheral Nervous System Diseases

Demyelinating Diseases


Neurologic Manifestations


Intensity-Modulated Radiation Therapy

Laboratory Biomarker Analysis






Radiation Therapy

Doxorubicin Hydrochloride


Morab-003 (Farletuzumab)

0.9% Saline

Topotecan Hydrochloride

Ac Regimen

Duloxetine Hydrochloride


Acetyl-L-Carnitine Hydrochloride

©2013 Applied Informatics, Inc.
As Seen On:
  • New York Times
  • USA Today
  • bio-itworld logo